Opioid Prescribing at Hospital Discharge Contributes to Chronic Opioid Use

Journal of General Internal Medicine

Volumn 31, Issue 5, 2016, Pages 478-485

  Calcaterra, Susan L ^a,b   Yamashita, Traci E ^a   Min, Sung Joon ^a   Keniston, Angela ^b   Frank, Joseph W ^a,c   Binswanger, Ingrid A ^a,d  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d KAISER PERMANENTE   (United States)

Author keywords

hospital medicine; pain; substance abuse

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

ADULT; ALCOHOL USE DISORDER; ARTICLE; CHRONIC PAIN; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEOPLASM; PHARMACY; PRESCRIPTION; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR; SAFETY NET HOSPITAL; COLORADO; DRUG ADMINISTRATION; MIDDLE AGED; OPIOID-RELATED DISORDERS; YOUNG ADULT;

ADULT; ANALGESICS, OPIOID; CHRONIC PAIN; COLORADO; DRUG ADMINISTRATION SCHEDULE; DRUG PRESCRIPTIONS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PATIENT DISCHARGE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84946782040     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-015-3539-4     Document Type: Article

References (89)

1. Sullivan MD, Edlund MJ, Fan MY, Devries A, Brennan Braden J, Martin BC. Trends in use of opioids for non-cancer pain conditions 2000–2005 in commercial and medicaid insurance plans: the TROUP study. Pain. 2008;138(2):440–449.
2. Larochelle MR, Zhang F, Ross-Degnan D, Wharam JF. Trends in opioid prescribing and co-prescribing of sedative hypnotics for acute and chronic musculoskeletal pain: 2001–2010. Pharmacoepidemiol Drug Saf. 2015;8(24):885–892.
3. Edlund MJ, Martin BC, Devries A, Fan MY, Braden JB, Sullivan MD. Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin. J. Pain. 2010;26(1):1–8.
4. Zerzan JT, Morden NE, Soumerai S, et al. Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. Med Care. 2006;44(11):1005–1010.
5. Centers for Disease Control and Prevention. Unintentional Drug Poisoning in the United States. 2010. http://www.cdc.gov/HomeandRecreationalSafety/pdf/poison-issue-brief.pdf. Accessed 8 2015.
6. Governale L. Outpatient prescription opioid utilization in the U.S., years 2000–2009.U.S. Food and Drug Administration. 2010. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndLifeSupportDrugsAdvisoryCommittee/UCM220950.pdf. Accessed 8 2015
7. Manchikanti KN, Manchikanti L, Damron KS, Pampati V, Fellows B. Increasing deaths from opioid analgesics in the United States: an evaluation in an interventional pain management practice. J. Opioid Manag. 2008;4(5):271–283.
8. Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician. 2010;13(5):401–435.
9. Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med. 2010;363(21):1981–1985.
10. Warner M, Chen LH, Makuc DM, Anderson RN, Minino AM. Drug poisoning deaths in the United States 1980–2008. NCHS Data Brief. 2011;81:1–8.
11. Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999–2009. Drug Alcohol Depend. 2013;131(3):263–270.
12. Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006;15(9):618–627.
13. Paulozzi LJ, Ryan GW. Opioid analgesics and rates of fatal drug poisoning in the United States. Am J Prev Med. 2006;31(6):506–511.
14. Becker WC, Tobin DG, Fiellin DA. Nonmedical use of opioid analgesics obtained directly from physicians: prevalence and correlates. Arch Intern Med. 2011;171(11):1034–1036.
15. Ringwalt C, Gugelmann H, Garrettson M, et al. Differential prescribing of opioid analgesics according to physician specialty for Medicaid patients with chronic noncancer pain diagnoses. Pain Res Manag. 2014;19(4):179–185.
16. Volkow ND, McLellan TA, Cotto JH, Karithanom M, Weiss SR. Characteristics of opioid prescriptions in 2009. J. Am. Med. Assoc. 2011;305(13):1299–1301.
17. Sehgal N, Manchikanti L, Smith HS. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician. 2012;15(3 Suppl):Es67–92.
18. Manchikanti L, Abdi S, Atluri S, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2—guidance. Pain Physician. 2012;15(3 Suppl):S67–116.
19. Grattan A, Sullivan MD, Saunders KW, Campbell CI, Von Korff MR. Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse. Ann Fam Med. 2012;10(4):304–311.
20. Sox HC. The hospitalist model: perspectives of the patient, the Internist, and internal medicine. Ann Intern Med. 1999;130(4 Pt 2):368–372.
21. Wachter RM, Goldman L. The hospitalist movement 5 years later. J. Am. Med. Assoc. 2002;287(4):487–494.
22. Davis KM, Koch KE, Harvey JK, Wilson R, Englert J, Gerard PD. Effects of hospitalists on cost, outcomes, and patient satisfaction in a rural health system. Am J Med. 2000;108(8):621–626.
23. Auerbach AD, Wachter RM, Katz P, Showstack J, Baron RB, Goldman L. Implementation of a voluntary hospitalist service at a community teaching hospital: improved clinical efficiency and patient outcomes. Ann Intern Med. 2002;137(11):859–865.
24. Meltzer D, Manning WG, Morrison J, et al. Effects of physician experience on costs and outcomes on an academic general medicine service: results of a trial of hospitalists. Ann Intern Med. 2002;137(11):866–874.
25. Rachoin JS, Skaf J, Cerceo E, et al. The impact of hospitalists on length of stay and costs: systematic review and meta-analysis. Am J Manag Care. 2012;18(1):e23–30.
26. White HL, Glazier RH. Do hospitalist physicians improve the quality of inpatient care delivery? a systematic review of process, efficiency and outcome measures. BMC Med. 2011;9:58.
27. Bell CM, Schnipper JL, Auerbach AD, et al. Association of communication between hospital-based physicians and primary care providers with patient outcomes. J Gen Intern Med. 2009;24(3):381–386.
28. Kripalani S, Jackson AT, Schnipper JL, Coleman EA. Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists. J Hosp Med. 2007;2(5):314–323.
29. Arora VM, Prochaska ML, Farnan JM, et al. Problems after discharge and understanding of communication with their primary care physicians among hospitalized seniors: a mixed methods study. J Hosp Med. 2010;5(7):385–391.
30. Lo B. Ethical and policy implications of hospitalist systems. Am J Med. 2001;111(9b):48–52.
31. Pantilat SZ, Lindenauer PK, Katz PP, Wachter RM. Primary care physician attitudes regarding communication with hospitalists. Am J Med. 2001;111(9b):15s–20s.
32. Price AM, Ilgen MA, Bohnert AS. Prevalence and correlates of nonmedical use of prescription opioids in patients seen in a residential drug and alcohol treatment program. J Subst Abus Treat. 2011;41(2):208–214.
33. Sullivan MD, Edlund MJ, Zhang L, Unutzer J, Wells KB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med. 2006;166(19):2087–2093.
34. Sullivan MD, Edlund MJ, Steffick D, Unutzer J. Regular use of prescribed opioids: association with common psychiatric disorders. Pain. 2005;119(1–3):95–103.
35. Desbiens NA, Wu AW. Pain and suffering in seriously ill hospitalized patients. J Am Geriatr Soc. 2000;48(5 Suppl):S183–186.
36. Abbott FV, Gray-Donald K, Sewitch MJ, Johnston CC, Edgar L, Jeans ME. The prevalence of pain in hospitalized patients and resolution over six months. Pain. 1992;50(1):15–28.
37. Marks RM, Sachar EJ. Undertreatment of medical inpatients with narcotic analgesics. Ann Intern Med. 1973;78(2):173–181.
38. Edlund MJ, Martin BC, Fan MY, Devries A, Braden JB, Sullivan MD. Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study. Drug Alcohol Depend. 2010;112(1–2):90–98.
39. Edlund MJ, Steffick D, Hudson T, Harris KM, Sullivan M. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain. 2007;129(3):355–362.
40. Madras BK, Compton WM, Avula D, Stegbauer T, Stein JB, Clark HW. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. Drug Alcohol Depend. 2009;99(1):280–295.
41. Bartoli F, Scarone S, Clerici M. Risk of hospitalization among patients with co-occurring psychotic and substance use disorders: a 12-year follow-up. Riv Psichiatr. 2013;48(1):51–59.
42. Hoblyn JC, Balt SL, Woodard SA, Brooks JO III. Substance use disorders as risk factors for psychiatric hospitalization in bipolar disorder. Psychiatr Serv. 2009;60(1):50–55.
43. Sepehrmanesh Z, Ahmadvand A, Moraveji A. Comorbidity and pattern of substance use in hospitalized psychiatric patients. Iran Red Crescent Med J. 2014;16(8), e19282.
44. Ryan AM. Has pay-for-performance decreased access for minority patients? Health Serv Res. 2010;45(1):6–23.
45. Ryan A. Hospital-based pay-for-performance in the United States. Health Econ. 2009;18(10):1109–1113.
46. Giordano LA, Elliott MN, Goldstein E, Lehrman WG, Spencer PA. Development, Implementation, and Public Reporting of the HCAHPS Survey. Medical Care Research and Review. 2009
47. Chatterjee P, Joynt KE, Orav E, Jha AK. Patient experience in safety-net hospitals: Implications for improving care and value-based purchasing. Arch Intern Med. 2012;172(16):1204–1210.
48. Gupta A, Lee LK, Mojica JJ, Nairizi A, George SJ. Patient perception of pain care in the United States: a 5-year comparative analysis of hospital consumer assessment of health care providers and systems. Pain Physician. 2014;17(5):369–377.
49. Gupta A, Daigle S, Mojica J, Hurley RW. Patient perception of pain care in hospitals in the United States. J Pain Res. 2009;2:157–164.
50. Craig AR, Otani K, Herrmann PA. Evaluating the influence of perceived pain control on patient satisfaction in a hospital setting. Hosp Top. 2015;93(1):1–8.
51. Zgierska A, Miller M, Rabago D. Patient satisfaction, prescription drug abuse, and potential unintended consequences. JAMA. 2012;307(13):1377–1378.
52. Frantsve LM, Kerns RD. Patient-provider interactions in the management of chronic pain: current findings within the context of shared medical decision making. Pain medicine (Malden, Mass). 2007;8(1):25–35.
53. Houle SK, McAlister FA, Jackevicius CA, Chuck AW, Tsuyuki RT. Does performance-based remuneration for individual health care practitioners affect patient care?: a systematic review. Ann Intern Med. 2012;157(12):889–899.
54. Scott A, Sivey P, Ait Ouakrim D, et al. The effect of financial incentives on the quality of health care provided by primary care physicians. Cochrane Database Syst. Rev. 2011;7(9):Cd008451.
55. Wright M. Pay-for-performance programs—do they improve the quality of primary care? Aust Fam Physician. 2012;41(12):989–991.
56. Manary MP, Boulding W, Staelin R, Glickman SW. The patient experience and health outcomes. N Engl J Med. 2013;368(3):201–203.
57. Yun L, Boles RE, Haemer MA, et al. A randomized, home-based, childhood obesity intervention delivered by patient navigators. BMC Public Health. 2015;15:506.
58. Davidson AJ, McCormick EV, Dickinson LM, Haemer MA, Knierim SD, Hambidge SJ. Population-level obesity surveillance: monitoring childhood body mass index z-score in a safety-net system. Acad Pediatr. 2014;14(6):632–638.
59. Allison MA, Crane LA, Beaty BL, Davidson AJ, Melinkovich P, Kempe A. School-based health centers: improving access and quality of care for low-income adolescents. Pediatrics. 2007;120(4):e887–894.
60. Von Korff M, Saunders K, Thomas Ray G, et al. De facto long-term opioid therapy for noncancer pain. The Clinical journal of pain. 2008;24(6):521–527.
61. Raebel MA, Newcomer SR, Bayliss EA, et al. Chronic opioid use emerging after bariatric surgery. Pharmacoepidemiol Drug Saf. 2014;23(12):1247–1257.
62. Boudreau D, Von Korff M, Rutter CM, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009;18(12):1166–1175.
63. Centers for Disease Control and Prevention. Classification of Diseases, Functioning, and Disability. 2013. http://www.cdc.gov/nchs/icd.htm. (Accessed 8/2015).
64. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
65. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–1251.
66. Colorado Uniform Controlled Subtances Act of 1992. Title 18. Criminal Code, Article 18. Uniform Controlled Substances Act, revised and effective July 1, 2014. http://cdn.colorado.gov/cs/Satellite?blobcol=urldata&blobheadername1=Content-Disposition&blobheadername2=Content-Type&blobheadervalue1=inline%3B+filename%3D%22Uniform+Controlled+Substances+Act.pdf%22&blobheadervalue2=application%2Fpdf&blobkey=id&blobtable=MungoBlobs&blobwhere=1252059209963&ssbinary=true. (Accesed 8/2015).
67. Raebel MA, Newcomer SR, Reifler LM, et al. Chronic use of opioid medications before and after bariatric surgery. JAMA. 2013;310(13):1369–1376.
68. Alam A, Gomes T, Zheng H, Mamdani MM, Juurlink DN, Bell CM. Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch Intern Med. 2012;172(5):425–430.
69. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain. 2010;150(3):573–581.
70. Finnerup NB, Otto M, Jensen TS, Sindrup SH. An evidence-based algorithm for the treatment of neuropathic pain. Med Gen Med. 2007;9(2):36.
71. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005;118(3):289–305.
72. Simpson CA. Complementary medicine in chronic pain treatment. Phys Med Rehabil Clin N Am. 2006;17(2):451–472. viii.
73. Turk DC, Wilson HD, Cahana A. Treatment of chronic non-cancer pain. Lancet. 2011;377(9784):2226–2235.
74. Frey Law LA, Evans S, Knudtson J, Nus S, Scholl K, Sluka KA. Massage reduces pain perception and hyperalgesia in experimental muscle pain: a randomized, controlled trial. The J Pain: Off J Ame Pain Society. 2008;9(8):714–721.
75. Furlan AD, Brosseau L, Imamura M, Irvin E. Massage for low-back pain: a systematic review within the framework of the Cochrane collaboration back review group. Spine. 2002;27(17):1896–1910.
76. Dansie EJ, Turk DC, Martin KR, Van Domelen DR, Patel KV. Association of chronic widespread pain with objectively measured physical activity in adults: findings from the national health and nutrition examination survey. J Pain. 2014;15(5):507–515.
77. Sutcliffe S, Colditz GA, Pakpahan R, et al. Changes in symptoms during urologic chronic pelvic pain syndrome symptom flares: findings from one site of the MAPP research network. Neurourol Urodyn. 2015;34(2):188–195.
78. Scholich SL, Hallner D, Wittenberg RH, Hasenbring MI, Rusu AC. The relationship between pain, disability, quality of life and cognitive-behavioural factors in chronic back pain. Disabil Rehabil. 2012;34(23):1993–2000.
79. Erfani T, Keefe F, Bennell K, Chen J, Makovey J. Psychological factors and pain exacerbation in knee osteoarthritis: a Web-based case-crossover study. Rheumatology (Sunnyvale) S. 2015;6:2161–1149.
80. Lampe A, Sollner W, Krismer M, et al. The impact of stressful life events on exacerbation of chronic low-back pain. J Psychosom Res. 1998;44(5):555–563.
81. van Hecke O, Torrance N, Smith BH. Chronic pain epidemiology and its clinical relevance. Br J Anaesth. 2013;111(1):13–18.
82. Mosher HJ, Jiang L, Vaughan Sarrazin MS, Cram P, Kaboli PJ, Vander Weg MW. Prevalence and characteristics of hospitalized adults on chronic opioid therapy. J Hosp Med. 2014;9(2):82–87.
83. Fields HL, Margolis EB. Understanding opioid reward. Trends Neurosci. 2015;38(4):217–25.
84. U.S. Department of Justice. Drug Enforcement Agency. Schedules of Controlled Substances: Rescheduling of Hydrocodone Combination Products From Schedule III to Schedule II. Federal Register. 2014;79(163): 49,661-49,682. http://www.deadiversion.usdoj.gov/fed_regs/rules/2014/fr0822.htm. (Accessed 8/2015).
85. Flegal KM, Brownie C, Haas JD. The effects of exposure misclassification on estimates of relative risk. Am J Epidemiol. 1986;123(4):736–751.
86. Hofler M. The effect of misclassification on the estimation of association: a review. Int J Methods Psychiatr Res. 2005;14(2):92–101.
87. Copeland KT, Checkoway H, McMichael AJ, Holbrook RH. Bias due to misclassification in the estimation of relative risk. Am J Epidemiol. 1977;105(5):488–495.
88. Hall MJ, DeFrances CJ, Williams SN, Golosinskiy A, Schwartzman A. National hospital discharge survey: 2007 summary. Natl Health Stat Report. 2010;24:1–20.
89. Centers for Disease Control and Prevention. Vital Signs. Opioid Painkiller Prescribing: Where You Live Makes a Difference. 2014. http://www.cdc.gov/vitalsigns/opioid-prescribing/. (Accessed 8/2015).